ZeroStack Corp.
NCM: ZSTKLive Quote
📈 ZcoreAI Score
Our AI model analyzes ZeroStack Corp.'s price action across multiple timeframes using regression channels and statistical scoring.
Get ZSTK Z-Score →About ZeroStack Corp.
Financial Services
Asset Management
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
📊 Fundamental Analysis
ZeroStack Corp. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 22.3% revenue growth, which is well above average for the Financial Services sector.
Return on Equity (ROE) is -307.5%, which indicates that capital utilization is currently under pressure.
At a current price of $5.18, ZSTK currently trades near the bottom of its 52-week range (1%), indicating potential value or weakness (Range: $4.76 - $47.00).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$12.59M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
2.01
52W High
$47.00
52W Low
$4.76
Avg Volume
90K
Day High
Day Low